Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Newsfile News Releases

Nov 30, 2021 08:43 ET
NuGen Announces a $5.8M, 5-Year Distribution Agreement with Khotwa Medical Co. for its InsuJet(TM) Needle Free Injection Device and Accessories
NuGen and Khotwa Providing Access to Safe and Effective, Needle Free Injections to a World Plagued with Diabetes
Nov 30, 2021 08:42 ET
Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its Cepharanthine for Treatment of Mild to Moderate COVID-19 Infection
Toronto, Ontario--(Newsfile Corp. - November 30, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce the successful completion of its Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA), for which a pre-IND briefing package and meeting request letter was submitted in September 2021. The FDA has provided written responses to the Company regarding its clinical development plan for PD-001, a patented enteric-coated formulation of cepharanthine, as a potential oral antiviral pill for COVID-19. PharmaDrug believes the written response provides a path to agreements on IND-enabling studies, the design of a Phase 1/2 clinical study, and the overall clinical development plan to move PD-001 forward as an oral treatment for COVID-19. By extension, the FDA guidance also provides important insights on advancing PD-001 as a potential treatment for oncology indications as part of the Company's ongoing strategy of targeting rare and life-threatening conditions. The Company continues to focus on completing the remaining IND-enabling studies to support future clinical studies in 2022.
Nov 30, 2021 08:42 ET
Reklaim Announces Q3-2021 Financial Results and Provides Corporate Update
Continued Momentum with Sales up 1496%, Brands Purchasing Data up 127%, and New Features and Functionality Expected to Drive Further Growth in 2022
Nov 30, 2021 08:34 ET
Atrium Mortgage Investment Corporation Completes $30 Million Public Offering of Convertible Unsecured Subordinated Debentures
Toronto, Ontario--(Newsfile Corp. - November 30, 2021) - Atrium Mortgage Investment Corporation (TSX:AI, AI.DB.C, AI.DB.D, AI.DB.E and AI.DB.F) ("Atrium") is pleased to report that it has closed its previously announced public offering of $30 million aggregate principal amount of 5.00% convertible unsecured subordinated debentures of Atrium due December 31, 2028 with a syndicate of underwriters bookrun by TD Securities Inc. and RBC Capital Markets and co-led by CIBC Capital Markets, and including National Bank Financial Inc., BMO Capital Markets, Scotiabank, Canaccord Genuity Corp., iA Private Wealth Inc., Raymond James Ltd. and Echelon Wealth Partners Inc. Atrium has granted the underwriters an over-allotment option to purchase up to an additional $4.5 million aggregate principal amount of debentures, exercisable in whole or in part at any time for a period of up to 30 days following today's closing.
Nov 30, 2021 08:34 ET
Esports Entertainment Group's ggCircuit Launches New Product: OMEGA
Hoboken, New Jersey--(Newsfile Corp. - November 30, 2021) - Esports Entertainment Group, Inc. (NASDAQ: GMBL) (NASDAQ: GMBLW) (or the "Company") and their ggCircuit brand today announced OMEGA, a new revolutionary product offering for B2B customers.
Nov 30, 2021 08:30 ET
American Creek's JV Partner Tudor Gold Intersects 0.97 G/T Gold EQ Over 1,320M, Including 1.38 G/T Gold Eq Over 556.5 M, Ending In Strong Mineralization With 2.34 G/T Gold Eq Over 57M in Step Out hole
Cardston, Alberta--(Newsfile Corp. - November 30, 2021) - American Creek Resources Ltd. (TSXV: AMK) ("the Corporation") is pleased to present the most recent drill results from the 30,108 meter, 2021 resource expansion and definition drilling program for the Goldstorm Deposit at their flagship property, Treaty Creek (the "Project"), located within the Golden Triangle of Northwest British Columbia.
Nov 30, 2021 08:30 ET
BioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project to Improve Early Detection of Lung Cancer
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that its Quebec-based wholly-owned subsidiary BioMark Diagnostic Solutions Inc. ("BDS") will be participating in a sponsored research project which aims to enhance the efficiency of current lung cancer screening programs and facilitate the identification of individuals who would benefit from more invasive tests, such as lung biopsy. Total funding for this collaborative research project is about $3.5 million and is made possible in part with the financial support of the Ministère de l'Économie et de l'Innovation (MEI) as part of CQDM's SynergiQC program and from an exceptional donation made by Mr. Normand Lord to the IUCPQ Foundation.
Nov 30, 2021 08:30 ET
China Education Resources Inc. Increased Revenue for Q3 2021
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - China Education Resources, Inc. (TSXV: CHN) (OTCQB: CHNUF) ("CER") a leading ed-tech company with a technology platform of intelligent systems and content is pleased to announce increased revenues of over 68% for the period ending September 30, 2021.
Nov 30, 2021 08:30 ET
Choom Announces Q1 Financial Results with $5.07M of Net Income
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) ("Choom" or the "Company"), a Canadian retail Company focused on delivering an elevated customer experience through high quality service, is pleased to report its financial and operating results for Q1 2022, ending September 30, 2021.
Nov 30, 2021 08:30 ET
Forum Uranium and Energy Metal Project Review
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) ("Forum" or "the Company") is pleased to update shareholders with a review of the Company's exploration plans on its uranium, copper, nickel and palladium projects in Saskatchewan and its cobalt project in Idaho (Figure 1).
Nov 30, 2021 08:30 ET
Marble Secures Licensing Agreement with WiiBid for its Proprietary Marble Connect API and Appointment of New CFO
The licensing agreement enables integration of Marble Connect API with Canada's first digital mortgage marketplace
Nov 30, 2021 08:30 ET
McLaren Resources Commences Phase One Exploration Program on Its McCool Gold Property
Toronto, Ontario--(Newsfile Corp. - November 30, 2021) - McLaren Resources Inc. (CSE: MCL) (FSE: 3ML) ("McLaren" or the "Company") is pleased to announce that it has commenced a phase one exploration program on its 100%-owned McCool gold property which is located in the prolific Timmins Gold Region of Northeastern Ontario, Canada where over 70 million ounces of gold have been produced to date.
Nov 30, 2021 08:30 ET
Next Green Wave Exceeds Projections, Releases Q3 2021 FS
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", "NGW" or the "Company"), a premium seed-to-shelf craft cannabis producer, is pleased to announce the following financial update:
Nov 30, 2021 08:30 ET
Ridgeline Minerals Announces Nevada Gold Mines to Commence Drilling at the Swift Gold Project, Nevada
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Ridgeline Minerals Corp. (TSXV: RDG) (OTCQB: RDGMF) (FSE: 0GC0) ("Ridgeline" or the "Company") is pleased to announce that Nevada Gold Mines LLC ("NGM" or "Nevada Gold Mines"), a joint venture between Barrick Gold Corp. and Newmont Corp., has mobilized a drill rig to the Swift Gold Project ("Swift") located on the Cortez District of the Battle Mountain - Eureka mine trend (Figure 1). Ridgeline entered into an exploration earn-in agreement with NGM on September 22, 2021 (see press release HERE) where NGM can incur a minimum US$20 million (US$4 million guaranteed) in qualifying work expenditures over an initial five-year term to earn an initial 60% interest in the Swift gold project. NGM will have further options to increase its interest to a total 75% interest, subject to additional expenditures and commitments. Details of the initial single hole drill program to be completed in Q4, 2021 are highlighted below.
Nov 30, 2021 08:30 ET
Soligenix Proof of Concept Uncovers Potential Treatment Option for the World's 125 Million Psoriasis Sufferers
New York, New York--(Newsfile Corp. - November 30, 2021) - PCG Digital -- Proof of concept in the biopharmaceutical sector is a process. Efficacy tests are performed, results are recorded from each round of clinical trials, and formulation changes are made if necessary. Each iteration moves the treatment closer to an NDA filing, with an end goal of achieving FDA approval. The goal is to gather enough data during trials to make that happen. Sometimes, you get more than what you're looking for. That's what happened with Soligenix (NASDAQ: SNGX) during their clinical trials of SGX301 (HyBryte™), a treatment option for cutaneous T-cell lymphoma (CTCL). Their research into using visible fluorescent light to activate synthetic hypericin to treat CTCL plaques and lesions has uncovered a potential treatment option for psoriasis.
Nov 30, 2021 08:30 ET
Western Investment Company Files Q3 Statements and Reports Net Income of $331,655 for the Quarter, $554,478 Year to Date
High River, Alberta--(Newsfile Corp. - November 30, 2021) - The Western Investment Company of Canada Limited (TSXV: WI) ("WICC" or "Western") announces that it has filed its Q3 Financial Statements and MD&A on SEDAR.
Nov 30, 2021 08:25 ET
TraceSafe Strengthens Privacy Program with GDPR Compliance; Ready to Expand Presence in Europe and Global Markets
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Tracesafe Inc., (CSE: TSF) ("TraceSafe") announced today that it has received attestation of General Data Protection Regulation (GDPR) compliance after an independent audit, cementing its position as a leading privacy-first IoT platform for large-scale industrial and enterprise operations. With this attestation, TraceSafe has also covered the most comprehensive global regulatory frameworks including Canada's Personal Information Protection and Electronic Documents Act (PIPEDA), California's Consumer Privacy Act (CCPA) in the United States, Australia's Privacy Act and other key privacy regulations across the world.
Nov 30, 2021 08:03 ET
Avalon Publishes Tenth Annual Sustainability Report and Provides Update on Separation Rapids Lithium Project Activities
Toronto, Ontario--(Newsfile Corp. - November 30, 2021) - Avalon Advanced Materials Inc. (TSX: AVL) (OTCQB: AVLNF) ("Avalon" or "the Company") is pleased to announce that the Company has released its tenth annual comprehensive sustainability report, along with its 2021 annual filings including the audited financial statements.
Nov 30, 2021 08:00 ET
Aurora Solar Technologies Announces Insight(TM) Wafer Tracking Agreement to Accelerate Market Entry
North Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Aurora Solar Technologies Inc. (TSXV: ACU) ("Aurora", the "Company") is pleased to announce that it has entered into an agreement with Shanghai Baibart Intelligent Technology Co. Ltd. ("Baibart") for the development and supply of silicon wafer tracking systems to be used with Aurora's InsightTM data science product in the large China market. This agreement complements our previously announced partnership with WAVELABS and allows Aurora to offer wafer tracking as part of its Insight platform more broadly and rapidly for solar cell manufacturing yield management and optimization. The wafer tracking solution with Baibart is being integrated with Insight as part of the recently announced evaluation project in China.
Nov 30, 2021 08:00 ET
Bluesky Digital Assets Corp., Releases Its Q3, 2021 Financial Results
Toronto, Ontario--(Newsfile Corp. - November 30, 2021) - Bluesky Digital Assets Corp., (CSE: BTC) (CSE: BTC.PR.A) (OTCQB: BTCWF) ("Bluesky" or the "Corporation"), released today a summary of its Unaudited Q3, 2021 Interim Financial Statements for the three and nine months ended September 30, 2021. Key highlights include: